Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oncology|January 1, 1988
Modulation of sensitivity to mitoxantrone in human chronic myeloid leukemia cells by the antidepressant sintamilM P Chitnis, K Satyamoorthy, S G Pradhan, et al.
Cancer Drug Delivery|January 1, 1987
Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycinM P Chitnis, S G Pradhan, K Satyamoorthy, et al.
Oncology|January 1, 1989
Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cellsK Satyamoorthy, M P Chitnis, S G Pradhan, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1987
Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180S G Pradhan, M P Chitnis, V S Basrur, et al.
Oncology|January 1, 1984
In vitro enhancement of adriamycin cytotoxicity in human myeloid leukemia cells exposed to verapamilS G Pradhan, V S Basrur, M P Chitnis, et al.
Tumori|October 31, 1986
Augmentation of hydroxyurea cytotoxicity by sintamil in human chronic myeloid leukemia cellsS G Pradhan, M P Chitnis, V S Basrur, et al.
International Journal of Obesity (2005)|October 9, 2015
Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activityA Meadows, J H Lee, C-S Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1997
Radiation therapy for retinoblastoma: a retrospective review of 120 patientsD G Pradhan, A L Sandridge, P Mullaney, et al.
Nutrition & Diabetes|December 25, 2013
Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistanceX Ma, L Lin, J Yue, et al.
Cancer Research|November 13, 2003
Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancerSvend O Freytag, Hans Stricker, Jan Pegg, et al.
Pageof 2